See analyst estimates and all valuation multiples for Genomics & Personalized Medicine
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$20.0B | 11.1x | -84.4x | |
$14.1B | 3.3x | 12.2x | |
$11.9B | 4.1x | 32.4x | |
$5.7B | 7.2x | -23.4x | |
$2.9B | 5.2x | 104.2x | |
$2.1B | 2.4x | 13.8x | |
$2.1B | 4.4x | 20.9x | |
$1.8B | 5.0x | -12.2x | |
$1.7B | 5.2x | 76.9x | |
$1.0B | 1.6x | 17.0x | |
$841M | 1.4x | -5.4x | |
$819M | 6.1x | -0.8x | |
$701M | 4.5x | -3.0x | |
$697M | 2.0x | 23.8x | |
$644M | 2.1x | 12.3x | |
$445M | 0.5x | 13.1x | |
$404M | 54.3x | -4.4x | |
$393M | 4.5x | n/a | |
$336M | 6.6x | -5.4x | |
$328M | 2.2x | -1.6x | |
$313M | 3.7x | -4.5x | |
$305M | 1.0x | -32.2x | |
$259M | n/a | n/a | |
$253M | n/a | n/a | |
$242M | 0.8x | 4.9x | |
$241M | 100.9x | -15.2x | |
$233M | 54.3x | -43.9x | |
$200M | 10.8x | n/a | |
$199M | 66.9x | n/a | |
$170M | 2.5x | -4.3x | |
$157M | n/a | n/a | |
$144M | 22.5x | -0.8x | |
$94.1M | 1.7x | -1.3x | |
$91.5M | n/a | -0.6x | |
$87.5M | 18.6x | -0.5x | |
$76.3M | 30.5x | n/a | |
$31.7M | 0.7x | 4.9x | |
$25.7M | 0.5x | -0.4x | |
$18.1M | n/a | n/a | |
$12.3M | 17.1x | -0.1x | |
$10.1M | n/a | n/a | |
$9.7M | 0.3x | -0.2x | |
$2.6M | 1.6x | -0.0x | |
-$2.0M | -0.0x | 0.1x | |
-$2.7M | n/a | n/a | |
-$11.1M | n/a | 0.1x | |
-$12.5M | -0.2x | 0.1x | |
-$14.7M | -22.7x | 0.2x | |
-$17.6M | n/a | 0.2x | |
-$32.9M | n/a | n/a | |
-$41.9M | n/a | 0.5x | |
-$43.7M | -2.4x | n/a | |
-$64.3M | -2.5x | 0.3x | |
-$83.5M | -2.8x | 0.3x | |
-$90.1M | -4.0x | n/a | |
-$109M | -11.0x | 0.7x | |
-$143M | -3.1x | 1.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Genomics & Personalized Medicine